AKKARAJU SRINIVAS
Saledirector
- Shares
- 48,065
- Price
- $10.55
- Value
- $507.01K
- Date
- Sep 08, 2026
SEC FORM 4
Recent insider purchases and sales reported on SEC Form 4, with transaction date, insider, role, shares, price and a direct SEC source for every row.
| Date | Insider / role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| Sep 08, 2026 | AKKARAJU SRINIVAS director | Sale | 48,065 | $10.55 | $507.01K | SEC ↗ |
| Sep 08, 2026 | AKKARAJU SRINIVAS director | Purchase | 273,291 | $10.63 | $2.9M | SEC ↗ |
| Sep 08, 2026 | AKKARAJU SRINIVAS director | Purchase | 273,290 | $10.63 | $2.9M | SEC ↗ |
| Sep 08, 2026 | AKKARAJU SRINIVAS director | Sale | 48,066 | $10.55 | $507.02K | SEC ↗ |
| Sep 04, 2026 | AKKARAJU SRINIVAS director | Purchase | 220,070 | $11.17 | $2.46M | SEC ↗ |
| Sep 04, 2026 | AKKARAJU SRINIVAS director | Purchase | 220,070 | $11.17 | $2.46M | SEC ↗ |
| Aug 03, 2026 | Bradley Mark Christopher Chief Development Officer | Sale | 2,572 | $26.37 | $67.82K | SEC ↗ |
| Aug 03, 2026 | Hardiman Roy C. Chief Business & Strategy Ofcr | Sale | 2,692 | $26.37 | $70.99K | SEC ↗ |
| Aug 03, 2026 | Schroer John R. Chief Financial Officer | Sale | 3,282 | $26.37 | $86.55K | SEC ↗ |
| Aug 03, 2026 | Goldstein David M Chief Scientific Officer | Sale | 2,596 | $26.37 | $68.46K | SEC ↗ |
| Aug 03, 2026 | Drappa Jorn Chief Medical Officer | Sale | 2,447 | $26.37 | $64.53K | SEC ↗ |
| Aug 03, 2026 | Pangali Sanam Chief Legal Officer | Sale | 1,364 | $26.37 | $35.97K | SEC ↗ |
director
director
director
director
director
director
Chief Development Officer
Chief Business & Strategy Ofcr
Chief Financial Officer
Chief Scientific Officer
Chief Medical Officer
Chief Legal Officer
Only transactions explicitly classified as purchase (P) or sale (S) are shown. A filing does not guarantee the insider's outlook or future investment performance.